Agilent Technologies Gross Margin 2010-2025 | A

Current and historical gross margin for Agilent Technologies (A) over the last 10 years. The current gross profit margin for Agilent Technologies as of April 30, 2025 is %.
Agilent Technologies Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-04-30 $6.63B $3.54B 53.35%
2025-01-31 $6.53B $3.53B 53.97%
2024-10-31 $6.51B $3.54B 54.30%
2024-07-31 $6.50B $3.53B 54.39%
2024-04-30 $6.59B $3.34B 50.63%
2024-01-31 $6.74B $3.41B 50.56%
2023-10-31 $6.83B $3.47B 50.71%
2023-07-31 $6.99B $3.56B 50.93%
2023-04-30 $7.04B $3.84B 54.59%
2023-01-31 $6.93B $3.78B 54.55%
2022-10-31 $6.85B $3.72B 54.35%
2022-07-31 $6.66B $3.61B 54.21%
2022-04-30 $6.53B $3.52B 53.98%
2022-01-31 $6.45B $3.48B 53.98%
2021-10-31 $6.32B $3.41B 53.92%
2021-07-31 $6.14B $3.30B 53.65%
2021-04-30 $5.82B $3.11B 53.50%
2021-01-31 $5.53B $2.95B 53.38%
2020-10-31 $5.34B $2.84B 53.14%
2020-07-31 $5.22B $2.79B 53.34%
2020-04-30 $5.24B $2.81B 53.65%
2020-01-31 $5.24B $2.82B 53.88%
2019-10-31 $5.16B $2.81B 54.33%
2019-07-31 $5.09B $2.78B 54.54%
2019-04-30 $5.02B $2.74B 54.65%
2019-01-31 $4.99B $2.72B 54.48%
2018-10-31 $4.91B $2.68B 54.54%
2018-07-31 $4.81B $2.61B 54.25%
2018-04-30 $4.72B $2.55B 53.94%
2018-01-31 $4.62B $2.50B 54.05%
2017-10-31 $4.47B $2.40B 53.64%
2017-07-31 $4.39B $2.35B 53.48%
2017-04-30 $4.32B $2.30B 53.10%
2017-01-31 $4.24B $2.23B 52.68%
2016-10-31 $4.20B $2.20B 52.28%
2016-07-31 $4.13B $2.14B 51.96%
2016-04-30 $4.10B $2.12B 51.64%
2016-01-31 $4.04B $2.07B 51.11%
2015-10-31 $4.04B $2.04B 50.54%
2015-07-31 $4.81B $2.40B 49.98%
2015-04-30 $4.80B $2.39B 49.80%
2015-01-31 $4.83B $2.40B 49.65%
2014-10-31 $4.81B $2.39B 49.77%
2014-07-31 $4.72B $2.41B 50.92%
2014-04-30 $5.37B $2.76B 51.42%
2014-01-31 $6.11B $3.17B 51.80%
2013-10-31 $6.78B $3.54B 52.12%
2013-07-31 $6.83B $3.55B 51.95%
2013-04-30 $6.90B $3.58B 51.91%
2013-01-31 $6.90B $3.61B 52.30%
2012-10-31 $6.86B $3.60B 52.55%
2012-07-31 $6.82B $3.60B 52.84%
2012-04-30 $6.79B $3.61B 53.12%
2012-01-31 $6.73B $3.59B 53.29%
2011-10-31 $6.62B $3.53B 53.35%
2011-07-31 $6.46B $3.44B 53.26%
2011-04-30 $6.16B $3.28B 53.20%
2011-01-31 $5.75B $3.09B 53.67%
2010-10-31 $5.44B $2.93B 53.82%
2010-07-31 $5.04B $2.73B 54.22%
2010-04-30 $4.71B $2.54B 54.04%
2010-01-31 $4.53B $2.36B 52.19%
2009-10-31 $4.48B $2.29B 51.15%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $32.815B $6.510B
Agilent Technologies, Inc. is an original equipment manufacturer of a broad-based portfolio of test and measurement products serving multiple end markets. Recently, the company has diversified into new end markets, namely industrial, chemical and electronics markets. The company has three business segments, including Life Sciences & Applied Markets Group (LSAG), Diagnostics and Genomics Group (DGG) and Agilent Cross Lab Group (ACG).The company uses a direct sales model for the distribution of its products, which is supplemented by distributors, resellers, manufacturers' representatives, telesales and electronic commerce, as necessary.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $230.372B 27.70
Boston Scientific (BSX) United States $149.971B 37.54
Stryker (SYK) United States $142.469B 29.79
EssilorLuxottica (ESLOY) France $128.310B 0.00
Medtronic (MDT) Ireland $109.952B 15.59
Lonza Group Ag (LZAGY) Switzerland $49.265B 0.00
Haleon (HLN) United Kingdom $47.015B 26.80
ResMed (RMD) United States $36.786B 27.63
GE HealthCare Technologies (GEHC) United States $32.917B 15.63
Terumo (TRUMY) Japan $26.606B 34.56
Koninklijke Philips (PHG) Netherlands $21.242B 14.90
Insulet (PODD) United States $21.238B 83.37
Zimmer Biomet Holdings (ZBH) United States $17.915B 11.51
Baxter (BAX) United States $15.293B 11.42
Smith & Nephew SNATS (SNN) United Kingdom $12.517B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $9.087B 0.00
Bio-Rad Laboratories (BIO) United States $6.313B 21.97
Lantheus Holdings (LNTH) United States $5.465B 13.78
Prestige Consumer Healthcare (PBH) United States $4.133B 18.46
Perrigo (PRGO) Ireland $3.618B 9.17
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.366B 15.33
ICU Medical (ICUI) United States $3.165B 23.34
Envista Holdings (NVST) United States $3.154B 26.21
GN Store Nord (GNNDY) Denmark $2.272B 18.82
QuidelOrtho (QDEL) United States $1.916B 13.18
LeMaitre Vascular (LMAT) United States $1.846B 41.26
AtriCure (ATRC) United States $1.565B 0.00
Acuren (TIC) United States $1.335B 0.00
AdaptHealth (AHCO) United States $1.144B 11.62
Neogen (NEOG) United States $1.083B 13.86
Green Thumb Industries (GTBIF) United States $1.059B 23.81
BioLife Solutions (BLFS) United States $1.022B 0.00
Phibro Animal Health (PAHC) United States $0.971B 12.41
InMode (INMD) Israel $0.843B 8.50
Kestra Medical Technologies (KMTS) United States $0.796B 0.00
CeriBell (CBLL) United States $0.643B 0.00
Evolus (EOLS) United States $0.600B 0.00
Owens & Minor (OMI) United States $0.576B 4.78
Curaleaf Holdings (CURLF) Canada $0.547B 0.00
Capricor Therapeutics (CAPR) United States $0.545B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.512B 0.00
Valneva SE (VALN) France $0.487B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Tilray Brands (TLRY) Canada $0.386B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
SEMPERIT AG HLD (SEIGY) Austria $0.307B 0.00
Sanuwave Health (SNWV) United States $0.282B 0.00
Aurora Cannabis (ACB) Canada $0.263B 78.00
Viemed Healthcare (VMD) United States $0.260B 21.93
Cerus (CERS) United States $0.256B 0.00
Quanterix (QTRX) United States $0.248B 0.00
Sanara MedTech (SMTI) United States $0.245B 0.00
ZimVie (ZIMV) United States $0.240B 10.90
Canopy Growth (CGC) Canada $0.237B 0.00
Cresco Labs (CRLBF) United States $0.236B 0.00
Biote (BTMD) United States $0.218B 6.14
OraSure Technologies (OSUR) United States $0.215B 0.00
Brainsway (BWAY) Israel $0.208B 55.15
TriSalus Life Sciences (TLSI) United States $0.204B 0.00
Verano Holdings (VRNOF) United States $0.192B 0.00
Omeros (OMER) United States $0.189B 0.00
High Tide (HITI) Canada $0.178B 0.00
Organigram Global (OGI) Canada $0.177B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
Exagen (XGN) United States $0.157B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
FitLife Brands (FTLF) United States $0.128B 15.76
Jin Medical (ZJYL) China $0.110B 0.00
Veru (VERU) United States $0.089B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.25
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
TerrAscend (TSNDF) Canada $0.077B 0.00
Agape ATP (ATPC) $0.076B 0.00
Zynex (ZYXI) United States $0.073B 0.00
Cytosorbents (CTSO) United States $0.073B 0.00
InterCure (INCR) Israel $0.068B 0.00
Apyx Medical (APYX) United States $0.065B 0.00
Jushi Holdings (JUSHF) United States $0.057B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
Modular Medical (MODD) United States $0.044B 0.00
Nephros (NEPH) United States $0.038B 51.14
United-Guardian (UG) United States $0.038B 12.98
Rockwell Medical (RMTI) United States $0.032B 0.00
Safety Shot (SHOT) United States $0.023B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
Cellectar Biosciences (CLRB) United States $0.017B 0.00
Flora Growth (FLGC) United States $0.016B 0.00
INLIF (INLF) $0.013B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.010B 0.00
Senestech (SNES) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00